Cargando…

Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022

Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao, Yang, Zijiang, Jiang, Jizong, Tang, Ming, Guan, Longfei, Lee, Hangil, Wang, Hongyun, Xu, Jiahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415707/
https://www.ncbi.nlm.nih.gov/pubmed/37576273
http://dx.doi.org/10.1016/j.heliyon.2023.e18809
_version_ 1785087605011906560
author Zhang, Xiao
Yang, Zijiang
Jiang, Jizong
Tang, Ming
Guan, Longfei
Lee, Hangil
Wang, Hongyun
Xu, Jiahong
author_facet Zhang, Xiao
Yang, Zijiang
Jiang, Jizong
Tang, Ming
Guan, Longfei
Lee, Hangil
Wang, Hongyun
Xu, Jiahong
author_sort Zhang, Xiao
collection PubMed
description Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002–2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD.
format Online
Article
Text
id pubmed-10415707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104157072023-08-12 Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022 Zhang, Xiao Yang, Zijiang Jiang, Jizong Tang, Ming Guan, Longfei Lee, Hangil Wang, Hongyun Xu, Jiahong Heliyon Research Article Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002–2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD. Elsevier 2023-07-29 /pmc/articles/PMC10415707/ /pubmed/37576273 http://dx.doi.org/10.1016/j.heliyon.2023.e18809 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Zhang, Xiao
Yang, Zijiang
Jiang, Jizong
Tang, Ming
Guan, Longfei
Lee, Hangil
Wang, Hongyun
Xu, Jiahong
Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title_full Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title_fullStr Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title_full_unstemmed Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title_short Engineering exosomes and their application in cardiovascular field: Bibliometric analysis from 2002 to 2022
title_sort engineering exosomes and their application in cardiovascular field: bibliometric analysis from 2002 to 2022
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415707/
https://www.ncbi.nlm.nih.gov/pubmed/37576273
http://dx.doi.org/10.1016/j.heliyon.2023.e18809
work_keys_str_mv AT zhangxiao engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT yangzijiang engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT jiangjizong engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT tangming engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT guanlongfei engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT leehangil engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT wanghongyun engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022
AT xujiahong engineeringexosomesandtheirapplicationincardiovascularfieldbibliometricanalysisfrom2002to2022